N. Vienney

661 total citations
7 papers, 292 citations indexed

About

N. Vienney is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, N. Vienney has authored 7 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Physiology and 2 papers in Immunology. Recurrent topics in N. Vienney's work include Pulmonary Hypertension Research and Treatments (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers) and Neonatal Respiratory Health Research (2 papers). N. Vienney is often cited by papers focused on Pulmonary Hypertension Research and Treatments (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers) and Neonatal Respiratory Health Research (2 papers). N. Vienney collaborates with scholars based in France, United States and Germany. N. Vienney's co-authors include Serge Adnot, Élisabeth Marcos, Valérie Amsellem, Bernard Maître, Mirna Saker, Larissa Lipskaia, Amal Houssaïni, Shariq Abid, Geneviève Dérumeaux and Marco Alifano and has published in prestigious journals such as Circulation Research, Arteriosclerosis Thrombosis and Vascular Biology and European Respiratory Journal.

In The Last Decade

N. Vienney

7 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Vienney France 5 164 94 72 61 42 7 292
Jennifer Judge United States 9 133 0.8× 120 1.3× 49 0.7× 31 0.5× 47 1.1× 16 334
Dongyu Ma China 9 165 1.0× 227 2.4× 29 0.4× 40 0.7× 101 2.4× 12 390
Indhu Subramanian United States 4 143 0.9× 125 1.3× 56 0.8× 28 0.5× 22 0.5× 7 328
Jai Prakash Muyal India 9 149 0.9× 100 1.1× 78 1.1× 23 0.4× 32 0.8× 16 315
Amanda Jagdis Canada 9 109 0.7× 70 0.7× 40 0.6× 65 1.1× 11 0.3× 16 317
Rebecca L. Harper United States 10 187 1.1× 126 1.3× 21 0.3× 23 0.4× 42 1.0× 17 310
Andor R. Kranenburg Netherlands 7 328 2.0× 113 1.2× 146 2.0× 44 0.7× 37 0.9× 7 465
Brian S. Comer United States 8 78 0.5× 175 1.9× 77 1.1× 94 1.5× 144 3.4× 11 351
Félix‐Antoine Bérubé‐Simard Canada 10 79 0.5× 168 1.8× 32 0.4× 16 0.3× 25 0.6× 15 264
Markus Arnold Switzerland 7 132 0.8× 87 0.9× 190 2.6× 30 0.5× 11 0.3× 17 287

Countries citing papers authored by N. Vienney

Since Specialization
Citations

This map shows the geographic impact of N. Vienney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Vienney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Vienney more than expected).

Fields of papers citing papers by N. Vienney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Vienney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Vienney. The network helps show where N. Vienney may publish in the future.

Co-authorship network of co-authors of N. Vienney

This figure shows the co-authorship network connecting the top 25 collaborators of N. Vienney. A scholar is included among the top collaborators of N. Vienney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Vienney. N. Vienney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Knoepp, Fenja, Shariq Abid, Amal Houssaïni, et al.. (2025). Piezo1 in PASMCs: Critical for Hypoxia-Induced Pulmonary Hypertension Development. Circulation Research. 136(9). 1031–1048. 4 indexed citations
2.
Beaulieu, Delphine, Marielle Breau, Larissa Lipskaia, et al.. (2021). Phospholipase A2 receptor 1 promotes lung cell senescence and emphysema in obstructive lung disease. European Respiratory Journal. 58(2). 2000752–2000752. 16 indexed citations
3.
Abid, Shariq, Élisabeth Marcos, Aurélien Parpaleix, et al.. (2019). CCR2/CCR5-mediated macrophage–smooth muscle cell crosstalk in pulmonary hypertension. European Respiratory Journal. 54(4). 1802308–1802308. 99 indexed citations
4.
Beaulieu, Delphine, Marielle Breau, Larissa Lipskaia, et al.. (2019). Phospholipase A2 Receptor 1 Promotes Lung-Cell Senescence and Emphysema in Obstructive Lung Disease. A3762–A3762. 1 indexed citations
5.
Saker, Mirna, Larissa Lipskaia, Élisabeth Marcos, et al.. (2016). Osteopontin, a Key Mediator Expressed by Senescent Pulmonary Vascular Cells in Pulmonary Hypertension. Arteriosclerosis Thrombosis and Vascular Biology. 36(9). 1879–1890. 44 indexed citations
6.
Gary‐Bobo, Guillaume, Marco Alifano, Élisabeth Marcos, et al.. (2011). Pulmonary Artery Smooth Muscle Cell Senescence Is a Pathogenic Mechanism for Pulmonary Hypertension in Chronic Lung Disease. Circulation Research. 109(5). 543–553. 114 indexed citations
7.
Dauphin, Aurélien, et al.. (2001). Effect of desiccation on potassium and anion currents from young root hairs: Implication on tip growth. Physiologia Plantarum. 113(1). 79–84. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026